Kennislacunes

There is a lack of literature on topical therapy. We want to stimulate collegues to document their experience with topical treatment of myositis associated skin lesions, especially with a new class of potentially effective topical JAK inhibitors becoming available in the coming years. This result in the following research question: What are the effects of symptomatic topical therapies in patients with idiopathic inflammatory myopathy (IIM) or juvenile dermatomyositis?